Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M771Revenue $M115Net Margin (%)15.3Altman Z-Score10.2
Enterprise Value $M708EPS $0.3Operating Margin %27.8Piotroski F-Score7
P/E(ttm)41.9Beneish M-Score-2.0Pre-tax Margin (%)27.9Higher ROA y-yY
Price/Book8.210-y EBITDA Growth Rate %--Quick Ratio3.9Cash flow > EarningsY
Price/Sales6.35-y EBITDA Growth Rate %--Current Ratio3.9Lower Leverage y-yY
Price/Free Cash Flow25.1y-y EBITDA Growth Rate %88.1ROA % (ttm)13.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)24.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.2ROIC % (ttm)48.4Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SCMPJoel Greenblatt 2015-03-31 Buy 0.01%$13.12 - $18.56
($15.5)
$ 17.0710%New holding103,538
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SCMP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Kuno Sachiko10% Owner 2015-03-31Sell1,600,000$1421.93view
S&R Technology Holdings, LLC10% Owner 2015-03-31Sell1,186,113$1421.93view
Ueno Ryuji10% Owner 2015-03-31Sell1,600,000$1421.93view
Ashton WilliamDirector 2015-03-12Sell129,766$17.42-2.01view
Celeste Anthony C.Director 2015-03-11Sell65,966$17.34-1.56view
Claiborne Cary JFormer Chief Financial Officer 2014-12-16Sell50,000$12.9132.22view
S&R Technology Holdings, LLC10% Owner 2014-08-07Sell181,727$6.28171.82view
Ueno Ryuji10% Owner 2014-08-07Sell181,727$6.28171.82view
Kuno Sachiko10% Owner 2014-08-07Sell181,727$6.28171.82view
Kuno Sachiko10% Owner 2014-08-04Sell140,873$6.02183.55view

Quarterly/Annual Reports about SCMP:

News about SCMP:

Articles On GuruFocus.com
NeoPhotonics Delivers Sustained Profitability; Gevo Continues Biofuel Deal Momentum May 08 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
comment on SCMP Mar 06 2013 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 

More From Other Websites
Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference Jul 01 2015
Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference Jul 01 2015
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone) Jun 15 2015
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone) Jun 15 2015
Edited Transcript of SCMP earnings conference call or presentation 6-May-15 12:30pm GMT Jun 13 2015
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... May 29 2015
Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcare Conference May 27 2015
Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcare Conference May 27 2015
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 20 2015
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week May 15 2015
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week May 15 2015
SUCAMPO PHARMACEUTICALS, INC. Financials May 15 2015
Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthcare Conference May 13 2015
Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthcare Conference May 13 2015
Sucampo and Harbin Gloria Pharmaceuticals Enter Into Licensing Agreement for AMITIZA(R)... May 11 2015
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... May 11 2015
Sucampo and Harbin Gloria Pharmaceuticals Enter Into Licensing Agreement for AMITIZA(R)... May 11 2015
10-Q for Sucampo Pharmaceuticals, Inc. May 08 2015
Sucampo Stock Rebounds As Drug Gets Fast-Track Review May 08 2015
10-K for Sucampo Pharmaceuticals, Inc. May 07 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK